Ukraine Issues Its First Medical Cannabis Prescriptions to Veterans

The first medical cannabis prescriptions have been issued in Ukraine, marking the start of a program for people suffering from serious and chronic conditions, including veterans affected by the ongoing war and patients with neurological disorders.

First Dispensations of medical cannabis in Ukraine

According to the Ukrainian Ministry of Health, the national medical cannabis program is now up and running. The first patients received THC-based treatments last Thursday in the city of Vinnytsia, where capsules containing cannabis oil were dispensed by a licensed pharmacy.

Among the first recipients are two veterans suffering from chronic neuropathic pain and phantom limb pain following amputations, as well as a woman with multiple sclerosis.

Officials emphasized the program’s clinical objective, noting that cannabis-based medications are being introduced as part of modern drug therapy. As stated by the Ukrainian National Service for the Control of Medicines and Pharmaceutical Products:

"Patients who suffer from severe pain on a daily basis and require modern treatments now have an additional option for accessing modern drug therapy."

Distribution is currently limited but expanding. Six pharmacies, all owned by a single licensed operator, are already authorized to sell medical cannabis products in Vinnytsia, Dnipro, Lviv, Ivano-Frankivsk, Ternopil, and Khmelnytskyi. Authorities expect that approximately 17 additional pharmacies will begin dispensing these treatments in the near future.

A strictly regulated pharmaceutical framework

The rollout is being carried out under strict regulatory oversight. The Ministry of Health has clarified that only licensed entities are authorized to manufacture, import, and wholesale and retail cannabis-based medicines. As the ministry states:

“The manufacture and distribution of medical cannabis-based medications may be carried out by commercial entities that hold licenses for the production, wholesale, and retail distribution, as well as the importation of medical products (with the exception of active pharmaceutical ingredients), and a license for activities involving narcotics, psychotropic substances, and precursors,” the Ministry of Health stated. “In addition to the license, commercial entities must also obtain a quota to prepare these medications in pharmacies.”

Nationwide, approximately 36 public entities and 30 private entities currently hold the necessary licenses, covering some 180 operational sites. Oversight responsibilities are shared among several institutions, including the Ministry of Health, the National Police, and the National Medicines Agency, while cultivation and processing fall under the jurisdiction of the Ministry of Agrarian Policy.

Veterans, Chronic Pain, and Changing Clinical Guidelines

The introduction of medical cannabis in Ukraine is closely linked to the war the country is currently experiencing. The legislation, enacted in 2024 by President Volodymyr Zelensky, was initially intended to treat conditions such as cancer-related symptoms and post-traumatic stress disorder (PTSD) associated with the ongoing conflict with Russia.

Therange of eligible conditions has since expanded and now includes chronic and neuropathic pain, spasticity, chemotherapy-related nausea and vomiting, Parkinson's disease, and other serious neurological disorders.

The inclusion of veterans among the first beneficiaries underscores the program’s focus on war-related trauma and long-term pain management, particularly for amputees and those with complex neurological injuries.

Political Debate and Legislative Process

The legalization process was not without resistance. The medical cannabis bill, initially approved by lawmakers in late 2023, ran into procedural roadblocks and repeated attempts to delay. Opposition lawmakers introduced amendments and resolutions aimed at repealing or blocking the measure, but these efforts ultimately failed.

The legislation was passed by a vote of 248, paving the way for its implementation in 2024. Previous statements from the Ministry of Health have clarified a major policy change:

“Cannabis, its resin, extracts, and tinctures are excluded from the list of particularly dangerous substances,” the Ministry of Health stated in a press release issued at the time. “Previously, their distribution was prohibited; now, it is permitted, but with certain restrictions.”

Political support for the reform is also coming directly from Volodymyr Zelensky, who advocated for access to cannabis-based medications for patients suffering from pain, stress, and war-related trauma. He said:

“All global best practices, all the most effective policies, and all solutions—no matter how difficult or unusual they may seem to us—must be implemented in Ukraine so that Ukrainians, all our citizens, do not have to endure the pain, stress, and trauma of war.”